Use of medications with anticholinergic properties and cognitive function in a young-old community sample

International Journal of Geriatric Psychiatry

Volumn 24, Issue 6, 2009, Pages 578-584

  Low, Lee Fay ^a   Anstey, Kaarin J ^b   Sachdev, Perminder ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anticholinergic; Attention; Cognitive decline; Memory

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

ACADEMIC ACHIEVEMENT; ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CALIFORNIA VERBAL LEARNING TEST; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE DEFECT; COMMUNITY SAMPLE; CONTROLLED STUDY; DEPRESSION; DIGITS BACKWARD; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; SELF REPORT; SEX DIFFERENCE; SIMPLE AND CHOICE REACTION TIME; SYMBOL DIGIT MODALITIES TEST;

ADULT; AGING; ATTENTION; CHOLINERGIC ANTAGONISTS; CHOLINERGIC FIBERS; COGNITION; COGNITION DISORDERS; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; REACTION TIME; TIME FACTORS; VERBAL LEARNING; YOUNG ADULT;

EID: 67649342779     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2157     Document Type: Article

References (38)

1. Aizenberg D, Sigler M, Weizman A, Barak Y. 2002. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-years case-control study. Int Psychogeriatr 1 4: 307-310.
2. Ancelin ML, Artero S, Portet F, et al. 2006. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332: 455-459.
3. Anstey KJ, Cherbnin N, Christensen H, et al. 2008. Follow-up of Mild Cogntive impairment and related disorders over 4 years in adults in their sixties: the PATH through life study. Dementia Geriatr Cog Disord. 26: 226-233.
4. Anstey KJ, Dear K, Christensen H, Jorm AF. 2005. Biomarkers, health, lifestyle, and demographic variables as correlates of reaction time performance in early, middle, and late adulthood. Quart J Experiment Psychol A 58: 5-21.
5. Baddeley A, Emsile H, Nimmo Smith I. 1992. The Spot-The-Word Test. Thames Valley Test Company: Bury St Edmonds.
6. Bottiggi KA, Salazar JC, Yu L, et al. 2006. Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry 14: 980.
7. Carnahan RM, Lund BC, Perry PJ, et al. 2002. The relationship of an anticholinergic rating scale with serum anticholinergic activity in elderly nursing home residents. Psychopharmacol Bull 36: 14-19.
8. Carnahan RM, Lund BC, Perry PJ, et al. 2006. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 46: 1481-1486.
9. Cohen J. 1988. Statistical Power for the Behavioral Sciences. Lawrence Erlbaum Associates: Hillsdale, NJ.
10. Davies P, Maloney AJ. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403.
11. Delis DC, Kramer JH, Kaplan E, Ober BA. 1987. California Verbal Learning Test. The Psychological Corporation: San Antonio, TX.
12. Fick DM, Cooper JW, Wade WE, et al. 2003. Updating the Beers Criteria for potentially inappropriate medication use in older adults: results of a US Consensus Panel of Experts. Arch Intern Med 163: 2716-2724.
13. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State'. A. practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12: 189-198.
14. Goldberg D, Bridges K, Duncan-Jones P, Grayson D. 1988. Detecting anxiety and depression in general medical settings. BMJ 297: 897-899.
15. Han L, McCusker J, Cole M, et al. 2001. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 161: 1099-1105.
16. Haywood KL, Garratt AM, Fitzpatrick R. 2005. Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res 14: 1651-1668.
17. Hilmer SN, Mager DE, Simonsick EM, et al. 2007. A Drug Burden Index to define the functional burden of medications in older people. Arch Intern Med 167: 781-787.
18. Jack CR, Jr, Petersen RC, Xu Yc, et al. 1999. Prediction of AD with MRI-based hippocampal volume in mild congitive impairment. Neurology 52: 1397-1403.
19. Landi F, Russo A, Liperoti R, et al. 2006. Anticholinergic drugs and physical function among a frail elderly population. Clin Pharmacol Therapeut 81: 235-241.
20. Lechevallier-Michel N, Gautier-Bertrand M, Alpérovitch A, et al. 2005a. Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Eur J Clin Pharmacol 60: 813-819.
21. Lechevallier-Michel N, Molimard M, Dartigues J-F, et al. 2005b. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol 59: 143-151.
22. Lezak MD, Mowieson DB, Loring DW. 2004. Neuropsychological Assessment. Oxford University Press: New York.
23. Marci LC, Benoit HM, Bruce GP. 2005. Serum Anticholinergic Activity and Cognition in Patients With Moderate-to-Severe Dementia. Am J Geriatr Psychiatry 13: 535.
24. Mintzer JE, Burns A. 2000. Anticholinergic side-effects of drugs in elderly people. J Royal Soc Med 93: 457-462.
25. Monane M, Avorn J, Beers MH, Everitt DE. 1993. Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med 153: 633-638.
26. Mulsant BH, Pollock BG, Kirshner M, et al. 2003. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 60: 198-203.
27. Nebes RD, Pollock BG, Halligan EM, et al. 2007. Serum Anticholinergic Activity and Motor Performance in Elderly Persons. J Gerontol A Biologic Medic Sci 62: 83-85.
28. Nebes RD, Pollock BG, Meltzer CC, et al. 2005. Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology 65: 1487-1489.
29. Perneger TV. 1998. What's wrong with Bonferroni adjustments. BMJ 316: 1236-1238.
30. Pomara N, Willoughby LM, Wesnes K, Sidtis JJ. 2004. Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: a controlled pilot study. Neuropsychopharmacol 29: 403-409.
31. Sarter M, Bruno JP. 1997. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Rev 23: 28-46.
32. Sarter M, Bruno JP, Givens B. 2003. Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory? Neurobiol Learn Memory 80: 245-256.
33. Schliebs R, Arendt T. 2006. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transmiss 113: 1625-1644.
34. Smith A. 1982. Digit Symbol Modalities Test SDMT Manual Revised. Western Psychological Services: Los Angeles, CA.
35. Tune L, Carr S, Hoag E, Cooper T. 1992. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 149: 1393-1394.
36. Ware J Jr, Kosinski M, Keller SD. 1996. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care 34: 220-233.
37. Ware JE, Kosinski M. 2001. Interpreting SF-36 summary health measures: a response. Qual Life Res 10: 405-413.
38. Weschler D. 1945. Weschler Memory Scale: The Psychological Corporation: San Antonio, TX.